dr. mato on immunotherapy options in cll
Published 5 years ago • 303 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:44
dr. mato on ibrutinib-based combinations in cll
-
1:10
dr. mato on the cll14 trial results in cll
-
1:50
dr. mato on ibrutinib versus acalabrutinib in cll
-
0:59
dr. mato on the use of biosimilars in cll
-
1:40
dr. mato on utilizing car t cells in cll
-
1:40
dr. mato on rituximab biosimilars in cll
-
1:17
dr. mato on managing side effects with ibrutinib/idelalisib in cll
-
2:04
dr. mato discusses a phase ii trial of umbralisib in cll
-
8:43
understanding chronic lymphocytic leukemia with anthony mato, md
-
1:00
dr. smith on ibrutinib-based therapies in cll
-
7:02
frontline treatment options in cll
-
6:57
chemoimmunotherapy in chronic lymphocytic leukemia
-
27:18
novel treatment options in cll
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
5:35
front-line chemoimmunotherapy in chronic lymphocytic leukemia
-
2:20
dr. awan on the role of chemotherapy in cll
-
1:02
dr. wierda on immunotherapy agents for patients with cll
-
1:12
dr. siddiqi on rationale for the transcend cll 004 trial in cll/sll
-
1:29
dr. mato discusses the safety and efficacy of umbralisib in cll